113 related articles for article (PubMed ID: 309866)
1. Surface membrane changes of T cells induced by syngeneic tumour cells. II. T-cell defects induced by small tumour cell inocula or tumour cell antigens.
Chow DA; Paraskevas F; Dular U
Int J Cancer; 1978 Nov; 22(5):621-9. PubMed ID: 309866
[TBL] [Abstract][Full Text] [Related]
2. Surface membrane changes of T cells induced by syngeneic tumour cells. I. Formation and uptake of complexes of Ig and tumour antigens by T cells.
Dular U; Chow DA; Paraskevas F
Int J Cancer; 1978 Nov; 22(5):611-20. PubMed ID: 82542
[TBL] [Abstract][Full Text] [Related]
3. Cell surface antigen expression on chemically induced murine leukaemias.
Birch JM; Moore M; Craig AW
Br J Cancer; 1975 Jun; 31(6):630-40. PubMed ID: 1174442
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
Friedman H; Kateley JR
Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
[TBL] [Abstract][Full Text] [Related]
5. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
Galli SJ; Adams RA
Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
[No Abstract] [Full Text] [Related]
6. Inhibition by sera and soluble antigens of T-cell-mediated cytotoxicity against leukaemia-associated antigens.
Ting CC; Rogers MJ
Nature; 1977 Apr; 266(5604):727-9. PubMed ID: 301609
[No Abstract] [Full Text] [Related]
7. The in vitro antibody response to cell surface antigens. II. Monoclonal antibodies to human leukemia cells.
Levy R; Dilley J
J Immunol; 1977 Aug; 119(2):394-400. PubMed ID: 301891
[TBL] [Abstract][Full Text] [Related]
8. Blocking of syngeneic effector T cells by soluble tumour antigens.
Plata F; Levy JP
Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
[No Abstract] [Full Text] [Related]
9. Cooperation of normal and malignant lymphoid cells in the immune response against sheep erythrocytes.
Boranić M; Hrsak I; Marotti T; Mazuran R; Silobrcić V
Biomedicine; 1974 Jan; 21(1):9-12. PubMed ID: 4858487
[No Abstract] [Full Text] [Related]
10. Immune response to Rauscher virus-induced leukemia in DBA mice. II. Correlation between antigenic expression and pathogenesis.
Tóth FD; Váczi L
Neoplasma; 1978; 25(3):265-72. PubMed ID: 79984
[TBL] [Abstract][Full Text] [Related]
11. The effect of anti-lymphocyte and anti-thymocyte serum on the pathogenesis of Rauscher leukaemia in inbred mouse strains.
Váczi L; Leövey A; Tóth FD; Kása M
Acta Microbiol Acad Sci Hung; 1976; 23(4):309-16. PubMed ID: 1088332
[TBL] [Abstract][Full Text] [Related]
12. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
13. Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytes.
Colombo MP; Arioli I; Parmiani G
Int J Cancer; 1984 Dec; 34(6):807-13. PubMed ID: 6334656
[TBL] [Abstract][Full Text] [Related]
14. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.
Minowada J; Tsubota T; Greaves MF; Walters TR
J Natl Cancer Inst; 1977 Jul; 59(1):83-7. PubMed ID: 301573
[TBL] [Abstract][Full Text] [Related]
15. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
Isakov N; Segal S; Hollander N; Feldman M
Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
[TBL] [Abstract][Full Text] [Related]
16. Growth of the Reh cell line in diffusion chambers. Evidence for differentiation along the T- and B-cell pathway.
Lau B; Jäger G; Thiel E; Rodt H; Huhn D; Pachmann K; Netzel B; Böning L; Thierfelder S; Dörmer P
Scand J Haematol; 1979 Oct; 23(4):385-92. PubMed ID: 395638
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
Lynch DH; Gurish MF; Daynes RA
Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
[TBL] [Abstract][Full Text] [Related]
18. Role of self carriers in the immune response and tolerance. X. A lymphoid dendritic-like tumor, P388AD.2, acts as a novel immunogenic carrier for hapten.
Cogswell JP; Phipps RP; Scott DW
J Immunol; 1986 Aug; 137(3):777-83. PubMed ID: 3522737
[TBL] [Abstract][Full Text] [Related]
19. A microtest radioimmunoassay for noncytotoxic tumor-specific antibody to cell-surface antigens.
Goldstein LT; Klinman NR; Manson LA
J Natl Cancer Inst; 1973 Nov; 51(5):1713-5. PubMed ID: 4762940
[No Abstract] [Full Text] [Related]
20. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
